K. Sudoh

发表

Vasopressin receptor antagonists: potential indications and clinical results.

Y. Arai, A. Fujimori, K. Sudoh, 2007, Current opinion in pharmacology.

Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.

K. Sudoh, K. Honda, H. Yazawa, 1992, The Journal of pharmacology and experimental therapeutics.

Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure.

Y. Arai, K. Sudoh, T. Takenaka, 1998, General pharmacology.

Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.

Y. Arai, A. Fujimori, K. Sudoh, 2005, European journal of pharmacology.

The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.

A. Fujimori, K. Sudoh, M. Sasamata, 2004, European journal of pharmacology.

A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

Y. Arai, A. Fujimori, K. Sudoh, 2007, Biological & pharmaceutical bulletin.

Pharmacological Characterization of YM598, a Selective Endothelin-A Receptor Antagonist

A. Fujimori, K. Sudoh, M. Sasamata, 2004, Journal of cardiovascular pharmacology.

A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats.

A. Fujimori, K. Sudoh, M. Sasamata, 2005, Vascular pharmacology.

In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ETA receptor antagonist, on the lower urinary tract

A. Fujimori, K. Sudoh, M. Sasamata, 2008 .

YM598, an Orally Active ETA Receptor Antagonist, Ameliorates the Progression of Cardiopulmonary Changes and Both-side Heart Failure in Rats with Cor Pulmonale and Myocardial Infarction

A. Fujimori, K. Sudoh, I. Yamaguchi, 2004, Journal of cardiovascular pharmacology.

Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain.

A. Fujimori, K. Sudoh, M. Sasamata, 2004, European journal of pharmacology.

Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.

A. Fujimori, K. Sudoh, J. Kazami, 2001, Chemical & pharmaceutical bulletin.

Inhibitory Effects of a Selective Endothelin-A Receptor Antagonist YM598 on Endothelin-1-induced Potentiation of Nociception in Formalin-induced and Prostate Cancer-induced Pain Models in Mice

A. Fujimori, K. Sudoh, M. Sasamata, 2004, Journal of cardiovascular pharmacology.

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist.

A. Fujimori, K. Sudoh, H. Harada, 2003, European journal of pharmacology.

Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists.

A. Fujimori, K. Sudoh, J. Kazami, 2001, Chemical & pharmaceutical bulletin.

Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs.

K. Sudoh, K. Honda, M. Shibasaki, 1992, Journal of autonomic pharmacology.

Effect of tamsulosin, a novel alpha 1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs.

K. Sudoh, T. Takenaka, H. Tanaka, 1996, Journal of autonomic pharmacology.

Effect of α1-adrenoceptor antagonists on urinary bladder function in urethane-anesthetized rats

K. Sudoh, T. Takenaka, O. Inagaki, 1997 .

Effect of alpha 1-adrenoceptor antagonists on urinary bladder function in urethane-anesthetized rats.

K. Sudoh, T. Takenaka, O. Inagaki, 1997, General pharmacology.

Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.

A. Fujimori, K. Sudoh, M. Orita, 2001, Bioorganic & medicinal chemistry.

Effect of single oral administration of YM598, a novel selective endothelin ETA receptor antagonist, on blood pressure in normotensive and hypertensive rats.

A. Fujimori, K. Sudoh, M. Sasamata, 2004, Vascular pharmacology.

Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.

A. Fujimori, K. Sudoh, M. Sasamata, 2004, European journal of pharmacology.